Drug sample provision and its effect on continuous drug therapy in an indigent care setting.
J Am Pharm Assoc (2003)
; 47(3): 366-72, 2007.
Article
en En
| MEDLINE
| ID: mdl-17510031
ABSTRACT
OBJECTIVE:
To assess the continuity and consistency of drug therapy among indigent patients following drug sample provision.DESIGN:
Retrospective study.SETTING:
Indigent ambulatory care. PATIENTS 129 adult patients, identified as having been given a drug sample between January 1, 2004, and February 27, 2004.INTERVENTIONS:
Analysis of data regarding the sample regimen, duration, rationale for sample provision, therapeutic indication, and subsequent therapy prescribed in the 6 months following sample provision. MAIN OUTCOMEMEASURES:
Lengths of gaps between sample provision and subsequent prescribed therapy were analyzed to evaluate the effect of sample provision on the continuity and consistency of drug therapy.RESULTS:
Of the 52 patients for whom continuous therapy was indicated, interruptions in therapy occurred in 50% (mean duration, 51.1 +/- 37.8 days; range, 2-123). Of the 65 patients who were prescribed subsequent therapy, 89.2% were prescribed the exact same drug, 9.2% a different drug in the same class, and 1.5% a different drug in a different class. Following sample provision, only 2 (3.1%) patients were prescribed generic medications.CONCLUSION:
Significant interruptions in drug therapy frequently followed sample provision in those requiring continuous treatment. On average, patients experienced interruptions in therapy for nearly 2 months. The majority of patients who were prescribed subsequent therapy were prescribed the same drug as the drug sample initially provided.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Preparaciones Farmacéuticas
/
Atención no Remunerada
/
Quimioterapia
Tipo de estudio:
Observational_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Am Pharm Assoc (2003)
Asunto de la revista:
FARMACIA
Año:
2007
Tipo del documento:
Article
País de afiliación:
Estados Unidos